1. Home
  2. STTK vs TG Comparison

STTK vs TG Comparison

Compare STTK & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • TG
  • Stock Information
  • Founded
  • STTK 2016
  • TG 1988
  • Country
  • STTK United States
  • TG United States
  • Employees
  • STTK N/A
  • TG N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • STTK Health Care
  • TG Industrials
  • Exchange
  • STTK Nasdaq
  • TG Nasdaq
  • Market Cap
  • STTK 56.8M
  • TG 267.5M
  • IPO Year
  • STTK 2020
  • TG 1989
  • Fundamental
  • Price
  • STTK $1.12
  • TG $7.76
  • Analyst Decision
  • STTK Hold
  • TG
  • Analyst Count
  • STTK 3
  • TG 0
  • Target Price
  • STTK $2.00
  • TG N/A
  • AVG Volume (30 Days)
  • STTK 182.2K
  • TG 122.4K
  • Earning Date
  • STTK 02-27-2025
  • TG 11-08-2024
  • Dividend Yield
  • STTK N/A
  • TG N/A
  • EPS Growth
  • STTK N/A
  • TG N/A
  • EPS
  • STTK N/A
  • TG N/A
  • Revenue
  • STTK $6,435,000.00
  • TG $717,366,000.00
  • Revenue This Year
  • STTK $313.04
  • TG N/A
  • Revenue Next Year
  • STTK N/A
  • TG N/A
  • P/E Ratio
  • STTK N/A
  • TG N/A
  • Revenue Growth
  • STTK 382.75
  • TG N/A
  • 52 Week Low
  • STTK $0.94
  • TG $3.98
  • 52 Week High
  • STTK $11.76
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • STTK 43.75
  • TG 52.54
  • Support Level
  • STTK $1.13
  • TG $7.49
  • Resistance Level
  • STTK $1.39
  • TG $8.09
  • Average True Range (ATR)
  • STTK 0.11
  • TG 0.33
  • MACD
  • STTK 0.00
  • TG -0.02
  • Stochastic Oscillator
  • STTK 18.18
  • TG 56.58

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: